The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common Diseases? [PDF]
Poppelaars F +3 more
europepmc +1 more source
Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy. [PDF]
Rajasekaran A +5 more
europepmc +1 more source
Factor H-related 1 and heparan sulfate architecture contribute to complement dysregulation in C3 glomerulopathy. [PDF]
Slagle AK +15 more
europepmc +1 more source
Targeting complement in IgA nephropathy. [PDF]
Caravaca-Fontán F +3 more
europepmc +1 more source
Levels of soluble complement regulators predict severity of COVID-19 symptoms. [PDF]
Tierney AL +6 more
europepmc +1 more source
Friend or foe: assessing the value of animal models for facilitating clinical breakthroughs in complement research. [PDF]
Poppelaars F, Holers VM, Thurman JM.
europepmc +1 more source
Mechanisms by which Factor H protects Trypanosoma cruzi from the alternative pathway of complement. [PDF]
Menon SS +6 more
europepmc +1 more source
Factor H-related 2 levels dictate FHR dimer composition. [PDF]
Veuskens BRJ +9 more
europepmc +1 more source
CTx001 for Geographic Atrophy: A Gene Therapy Expressing Soluble, Truncated Complement Receptor 1 (Mini-CR1). [PDF]
Rathi S +16 more
europepmc +1 more source

